Evidence map›Paper›PMID 40480281›Full record

ArticleJournal of the American Medical Directors Association2025

Frailty, Latent Health Profiles, and Antiretroviral Therapy: Predicting Success of Skilled Nursing Facility Care in an HIV Population.

Brianne L Olivieri-Mui, Ellen P McCarthy, Sandra M Shi, Ira B Wilson, Jieun Jang, Gahee Oh, Aneeka Ratnayake, Chan Mi Park, Dae Hyun Kim

Abstract read
In one paragraph

Article in Journal of the American Medical Directors Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Brianne L Olivieri-MuiThe Department of Public Health and Health Sciences, Northeastern University, Boston, MA, USA; The Roux Institute, Northeastern University, Portland, ME, USA; The Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, USA. Electronic address: b.mui@northeastern.edu.
Ellen P McCarthyThe Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, USA.
Sandra M ShiThe Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, USA.
Ira B WilsonThe Department of Health Services, Policy and Practice, Brown University, Providence, RI, USA.
Jieun JangThe Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, USA; Department of Preventive Medicine, College of Medicine, Dongguk University, Gyeongju, Republic of Korea.
Gahee OhThe Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, USA.
Aneeka RatnayakeThe Department of Public Health and Health Sciences, Northeastern University, Boston, MA, USA; The Roux Institute, Northeastern University, Portland, ME, USA.
Chan Mi ParkThe Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, USA.
Dae Hyun KimThe Department of Health Services, Policy and Practice, Brown University, Providence, RI, USA.

Funding

Translational Researchin Aging Trainnig ProgramT32AG023480 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI LIPSITZ, LEWIS · 2004 to 2024
$7.6M
Mid-Career Mentoring Award For Patient-Oriented Research in Frailty and Health OutcomesK24AG073527 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI Dae Hyun Kim · 2022 to 2026
$862k
Understanding antiretroviral adherence changes from the community to the nursing homeK01AG077972 · NIA · NORTHEASTERN UNIVERSITY · PI Brianne Olivieri-Mui · 2022 to 2026
$616k
NIA NIH HHS K01 AG077972NIA NIH HHS K24 AG073527NIA NIH HHS T32 AG023480
6 · The paper itself

Abstract

objectivesPeople with HIV (PWH) likely need short-term skilled nursing facility (SNF) care more than people with greater financial and social support to remain home. Therefore, we sought to understand how frailty among health profiles with distinct driving conditions, antiretroviral therapy (ART), and sociodemographic factors relate to success of short-term SNF for PWH.

designRetrospective cohort study. SETTING AND

participantsShort-term SNF stays for PWH.

methodsStays (n = 1640) were identified in a 2014-2019 Medicare 5% random sample. Zero-Inflated Poisson regression estimated rate ratios for home time lost in 1-year post-discharge by age (<65 vs 65+), health profiles established by latent profile analysis, frailty, and days covered by ART.

resultsOverall, 716 (44%) SNF stays were aged 65+, 1154 (70%) were male, 764 (47%) were Black, 321 (20%) were frail, and 784 (48%) had ART ≥80% of days before admission. There were 3 health profiles: substance use (SU; n = 467), cardiovascular and pulmonary (CV/PULM; n = 665), or multisystem including SU, CV, PULM, and mental health (MULTI; n = 508). Among stays aged <65, SU [rate ratio (95% confidence interval), 1.12 (1.09-1.15)] had more and MULTI [0.87 (0.85-0.89)] had fewer days lost than the CV/PULM group, but any ART carried higher rates of days lost compared with none. Among those aged 65+, SU [0.89 (0.85-0.92)] had fewer days lost, but MULTI [0.97 (0.94-1.00)] was similar in home time loss compared with the CV/PULM group. Having ART <80% of days [1.10 (1.06-1.13)], frailty [1.07 (1.03-1.11)], or pre-frailty [1.07 (1.04-1.10)] had higher rates of days lost. CONCLUSIONS AND IMPLICATIONS: Although health profiles may help identify conditions most likely impacting health of PWH, frailty may be key to identifying those having the highest needs and at risk for greater home time loss following SNF stays, with this impact varying by age.

Indexed as

Anti-Retroviral AgentsFrailtyHIV InfectionsSkilled Nursing FacilitiesAgedFemaleHumansMaleMedicareMiddle AgedRetrospective StudiesUnited StatesAnti-Retroviral AgentsfrailtyHIV and aginglatent profile analysisMedicaremultimorbidity

Identifiers

PMID40480281
PMCPMC12230771

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.